Atlas Trials

Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity

Clinical trial NCT04630210 · WITHDRAWN

Trial details

NCT number
NCT04630210
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-02-01
Primary completion
2025-01-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.